1. Current and Emerging Targets in Immunotherapy for Osteosarcoma
   Shinji Miwa et al, 2019, Journal of Oncology CrossRef
2. Development of an immune-related prognostic index associated with osteosarcoma
   Chao-Dong Yin et al, 2021, Bioengineered CrossRef
3. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma
   Chi Zhang et al, 2020, Aging CrossRef
4. Glucocorticoid induced TNF receptor family-related protein (GITR) – A novel driver of atherosclerosis
   Laura A. Bosmans et al, 2021, Vascular Pharmacology CrossRef
5. Bone sarcomas in the immunotherapy era
   Marie‐Françoise Heymann et al, 2021, British Journal of Pharmacology CrossRef
6. Osteosarcoma: A comprehensive review of management and treatment strategies
   Farzaneh Jafari et al, 2020, Annals of Diagnostic Pathology CrossRef
7. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
   Hang Liang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
8. Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
   Zenan Wang et al, 2019, Frontiers in Immunology CrossRef
9. Research progress in the mechanism and treatment of osteosarcoma
   Jichao Bian et al, 2023, Chinese Medical Journal CrossRef
10. Osteosarcoma and Metastasis
    Gaohong Sheng et al, 2021, Frontiers in Oncology CrossRef
11. Applying Osteosarcoma Immunology to Understand Disease Progression and Assess Immunotherapeutic Response
    Hillary G. Pratt et al, 2020, Current Advances in the Science of Osteosarcoma CrossRef
12. Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma
    Bingsheng Yang et al, 2021, Oncology Letters CrossRef
13. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
    Chenglong Chen et al, 2021, Cancer Letters CrossRef
14. A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma
    Fengyan Wang et al, 2023, Frontiers in Medicine CrossRef
15. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
    Pratistha Koirala et al, 2016, Scientific Reports CrossRef
16. Advances in sarcoma diagnostics and treatment
    Amanda R. Dancsok et al, 2017, Oncotarget CrossRef
17. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression
    Timothy M. Fan et al, 2020, Frontiers in Oncology CrossRef
18. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies
    Domenico Galati et al, 2018, Cytotherapy CrossRef
19. Biomaterials‐Boosted Immunotherapy for Osteosarcoma
    Chao Sun et al, 2024, Advanced Healthcare Materials CrossRef
20. Osteosarcoma, personalized medicine, and tissue engineering; an overview of overlapping fields of research
    Azam Bozorgi et al, 2021, Cancer Treatment and Research Communications CrossRef
21. Novel Immunotherapies for Osteosarcoma
    Yubao Lu et al, 2022, Frontiers in Oncology CrossRef
22. T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
    Zhan Wang et al, 2016, Frontiers in Immunology CrossRef
23. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
    Marie-Françoise Heymann et al, 2019, Cellular Immunology CrossRef